Safety and effectiveness of monthly intravenous ibandronate injections in a prospective, postmarketing, and observational study in Japanese patients with osteoporosis

OBJECTIVES: This postmarketing, observational study evaluated the safety and effectiveness of monthly intravenous (IV) ibandronate in Japanese patients with osteoporosis. METHODS: Eligible patients received monthly IV ibandronate 1 mg for 12 months. Adverse drug reactions (ADRs) were evaluated. Chan...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Osteoporos Sarcopenia
Autori principali: Takeuchi, Yasuhiro, Hashimoto, Junko, Nishida, Yosuke, Yamagiwa, Chiemi, Tamura, Takashi, Atsumi, Akihide
Natura: Artigo
Lingua:Inglês
Pubblicazione: Korean Society of Osteoporosis 2018
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6362972/
https://ncbi.nlm.nih.gov/pubmed/30775537
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.afos.2018.01.001
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi